rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-9-5
|
pubmed:abstractText |
There is growing evidence that ox-LDL plays an important role during the atherosclerosis process and PON1 can significantly inhibit generation of lipid peroxidation during LDL oxidation and thus play a role in the in vivo protection by HDL against atherosclerosis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0167-5273
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12957728-Adult,
pubmed-meshheading:12957728-Aged,
pubmed-meshheading:12957728-Aryldialkylphosphatase,
pubmed-meshheading:12957728-Biological Markers,
pubmed-meshheading:12957728-Cholesterol, LDL,
pubmed-meshheading:12957728-Coronary Angiography,
pubmed-meshheading:12957728-Coronary Disease,
pubmed-meshheading:12957728-Erythrocytes,
pubmed-meshheading:12957728-Female,
pubmed-meshheading:12957728-Humans,
pubmed-meshheading:12957728-Male,
pubmed-meshheading:12957728-Middle Aged,
pubmed-meshheading:12957728-Oxidative Stress,
pubmed-meshheading:12957728-Risk Factors,
pubmed-meshheading:12957728-Thiobarbituric Acid Reactive Substances
|
pubmed:year |
2003
|
pubmed:articleTitle |
PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease.
|
pubmed:affiliation |
Department of Biochemistry, Ege University Faculty of Medicine, Bornova, Izmir, Turkey.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|